Urogen Pharma Ltd. (URGN)
NASDAQ · Healthcare
Urogen Pharma Ltd. Long Term Debt 2016–2025
Urogen Pharma Ltd. annual long term debt history from 2022 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Urogen Pharma Ltd. long term debt as of December 31, 2025: 125.0M, a 2.68% increase year-over-year.
- Urogen Pharma Ltd. long term debt for 2025 were 125.0M, a 2.68% increase from 2024.
- Urogen Pharma Ltd. long term debt for 2024 were 121.7M, a 23.52% increase from 2023.
- Urogen Pharma Ltd. long term debt for 2023 were 98.6M, a 1.04% increase from 2022.
- Urogen Pharma Ltd. long term debt for 2022 were 97.5M.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Urogen Pharma Ltd. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $125 |
| 2024 | $122 |
| 2023 | $99 |
| 2022 | $98 |
Urogen Pharma Ltd. Long Term Debt — FAQ
Urogen Pharma Ltd. (URGN) long term debt over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see URGN's long term debt history?
The chart and table above show Urogen Pharma Ltd.'s long term debt by year and by quarter, including the growth rate.